Press release
Global and United States Daratumumab Injection Market Report & Forecast 2022-2028
This report focuses on global and United States Daratumumab Injection market, also covers the segmentation data of other regions in regional level and county level.Global Daratumumab Injection Scope and Market Size
Daratumumab Injection market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Daratumumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Daratumumab Injection market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
100 mg
400 mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Xi'an Janssen Pharmaceutical
Shanghai Henlius Biotech
Research Objectives
To study and analyze the global Daratumumab Injectionconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Daratumumab Injectionmarket by identifying its various subsegments.
Focuses on the key global Daratumumab Injectionmanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Daratumumab Injectionwith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Daratumumab Injectionsubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Study Coverage
1.1 Daratumumab Injection Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million) Introduction
1.2 Global Daratumumab Injection Outlook 2017 VS 2022 VS 2028
1.2.1 Global Daratumumab Injection Market Size for the Year 2017-2028
1.2.2 Global Daratumumab Injection Market Size for the Year 2017-2028
1.3 Daratumumab Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Daratumumab Injection in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Daratumumab Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Daratumumab Injection Market Dynamics
1.4.1 Daratumumab Injection Industry Trends
1.4.2 Daratumumab Injection Market Drivers
1.4.3 Daratumumab Injection Market Challenges
1.4.4 Daratumumab Injection Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Daratumumab Injection by Type
2.1 Daratumumab Injection Market Segment by Type
2.1.1 100 mg
2.1.2 400 mg
2.2 Global Daratumumab Injection Market Size by Type (2017, 2022 & 2028)
2.3 Global Daratumumab Injection Market Size by Type (2017-2028)
2.4 United States Daratumumab Injection Market Size by Type (2017, 2022 & 2028)
2.5 United States Daratumumab Injection Market Size by Type (2017-2028)
3 Daratumumab Injection by Application
3.1 Daratumumab Injection Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Daratumumab Injection Market Size by Application (2017, 2022 & 2028)
3.3 Global Daratumumab Injection Market Size by Application (2017-2028)
3.4 United States Daratumumab Injection Market Size by Application (2017, 2022 & 2028)
3.5 United States Daratumumab Injection Market Size by Application (2017-2028)
4 Global Daratumumab Injection Competitor Landscape by Company
4.1 Global Daratumumab Injection Market Size by Company
4.1.1 Top Global Daratumumab Injection Companies Ranked by Revenue (2021)
4.1.2 Global Daratumumab Injection Revenue by Player (2017-2022)
4.2 Global Daratumumab Injection Concentration Ratio (CR)
4.2.1 Daratumumab Injection Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Daratumumab Injection in 2021
4.2.3 Global Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Daratumumab Injection Headquarters, Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million) Type
4.3.1 Global Daratumumab Injection Headquarters and Area Served
4.3.2 Global Daratumumab Injection Companies Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Daratumumab Injection Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Daratumumab Injection Market Size by Company
4.5.1 Top Daratumumab Injection Players in United States, Ranked by Revenue (2021)
4.5.2 United States Daratumumab Injection Revenue by Players (2020, 2021 & 2022)
5 Global Daratumumab Injection Market Size by Region
5.1 Global Daratumumab Injection Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Daratumumab Injection Market Size by Region (2017-2028)
5.2.1 Global Daratumumab Injection Market Size by Region: 2017-2022
5.2.2 Global Daratumumab Injection Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Daratumumab Injection Market Size YoY Growth 2017-2028
6.1.2 North America Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Daratumumab Injection Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Daratumumab Injection Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Daratumumab Injection Market Size YoY Growth 2017-2028
6.3.2 Europe Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Daratumumab Injection Market Size YoY Growth 2017-2028
6.4.2 Latin America Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Daratumumab Injection Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Daratumumab Injection Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Details
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Daratumumab Injection Introduction
7.1.4 Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022)
7.1.5 Johnson & Johnson Recent Development
7.2 Xi'an Janssen Pharmaceutical
7.2.1 Xi'an Janssen Pharmaceutical Company Details
7.2.2 Xi'an Janssen Pharmaceutical Business Overview
7.2.3 Xi'an Janssen Pharmaceutical Daratumumab Injection Introduction
7.2.4 Xi'an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022)
7.2.5 Xi'an Janssen Pharmaceutical Recent Development
7.3 Shanghai Henlius Biotech
7.3.1 Shanghai Henlius Biotech Company Details
7.3.2 Shanghai Henlius Biotech Business Overview
7.3.3 Shanghai Henlius Biotech Daratumumab Injection Introduction
7.3.4 Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022)
7.3.5 Shanghai Henlius Biotech Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
If you would like to get a FREE sample, place an order, or have any questions, please enter
https://us.qyresearch.com/reports/347326/daratumumab-injection
Any doubts and questions will be welcome.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
This report focuses on global and United States Daratumumab Injection market, also covers the segmentation data of other regions in regional level and county level.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global and United States Daratumumab Injection Market Report & Forecast 2022-2028 here
News-ID: 2597095 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Daratumumab
Rising Incidence Of Bone Marrow Cancer Fuels Growth Of Daratumumab/Darzalex Mark …
What combination of drivers is leading to accelerated growth in the daratumumab or darzalex market?
The escalation of bone marrow cancer occurrences is anticipated to stimulate the expansion of the daratumumab or darzalex market. Bone marrow cancer entails cancers initiating in the bone marrow like multiple myeloma and leukemia which disrupt normal bodily functions due to abnormal blood cell production. The surge in bone marrow cancers is linked to an ageing…
Rising Incidence Of Bone Marrow Cancer Fuels Growth Of Daratumumab/Darzalex Mark …
What combination of drivers is leading to accelerated growth in the daratumumab or darzalex market?
The escalation of bone marrow cancer occurrences is anticipated to stimulate the expansion of the daratumumab or darzalex market. Bone marrow cancer entails cancers initiating in the bone marrow like multiple myeloma and leukemia which disrupt normal bodily functions due to abnormal blood cell production. The surge in bone marrow cancers is linked to an ageing…
Key Trend Reshaping the Daratumumab Or Darzalex Market in 2025: Focus On Transme …
What Are the Projections for the Size and Growth Rate of the Daratumumab Or Darzalex Market?
The market for daratumumab, also known as darzalex, has experienced swift expansion in the last few years. It is projected to escalate from $5,093.04 million in 2024 to $5,618.30 million in 2025 with a compound annual growth rate (CAGR) of 10.3%. This substantial growth during the historic period is primarily due to the use of…
Genmab/Janssen Biotech's Daratumumab market size expected to increase many folds …
DelveInsight has recently published a report on "Daratumumab Market Forecast Report" providing an in-depth analysis of the Daratumumab market analysis and forecasts up to 2032 in the seven major markets (7MM) (i.e. the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The comprehensive report provides an analysis of Daratumumab market potential and market share analysis in the AL Amyloidosis therapeutics space across the 7MM from…
Daratumumab Market Size, SWOT Analysis, Growth Statistics, Prominent Players Str …
This comprehensive Report of the Daratumumab Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. It represents a comprehensive and succinct analysis report of the main competitor and price statistics with a view to helping beginners establish their place and survive in…
AL Amyloidosis market size in the seven major markets was USD 920 million in 202 …
The AL Amyloidosis Market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.
The AL Amyloidosis market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted AL Amyloidosis…
